These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8176482)

  • 1. Orbitopathy after treatment of Graves' disease.
    Hurley JR
    J Nucl Med; 1994 May; 35(5):918-20. PubMed ID: 8176482
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy].
    Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A
    Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 4. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioactive iodine use in childhood Graves' disease: time to wake up and smell the I-131.
    Rivkees S
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4227-8. PubMed ID: 15356011
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
    Wartofsky L
    J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488
    [No Abstract]   [Full Text] [Related]  

  • 8. Graves' disease.
    Metso S; Jaatinen P; Salmi J
    N Engl J Med; 2008 Sep; 359(13):1408-9; author reply 1409. PubMed ID: 18822460
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of hypothyroidism following small doses of 131I in the treatment of Graves' disease.
    McCullagh EP; Jelden GL; Rodriguez-Antunez A
    Ohio State Med J; 1976 Sep; 72(9):538-40. PubMed ID: 989600
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal hyperthyroidism in the offspring of mothers with Graves' disease treated with radioiodine.
    García García E; Porras Cantarero JA; Fernández López P; Domínguez Gutiérrez de Ceballos R; Domínguez Pascual I
    Endocrinol Nutr; 2013 Nov; 60(9):e31-2. PubMed ID: 23490308
    [No Abstract]   [Full Text] [Related]  

  • 13. Early results of 125I therapy of thyrotoxic Graves' disease.
    Siemsen JK; Wallack MS; Martin RB; Nicoloff JT
    J Nucl Med; 1974 Apr; 15(4):257-60. PubMed ID: 4406129
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioiodine treatment of Graves' disease. An assessment of its potential risks.
    Graham GD; Burman KD
    Ann Intern Med; 1986 Dec; 105(6):900-5. PubMed ID: 3777715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scarred atrophic thyroid after I-131 therapy for Graves' disease documented at autopsy.
    Shih WJ; Mitchell B; Schott JC
    J Natl Med Assoc; 2002 Oct; 94(10):915-9. PubMed ID: 12408698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter: Reconsideration of 125-I therapy in Graves' disease.
    Deniach T
    Lancet; 1975 Apr; 1(7911):870. PubMed ID: 48113
    [No Abstract]   [Full Text] [Related]  

  • 18. [Radioactive iodine (I-131) therapy].
    Kusakabe K; Maki M
    Nihon Rinsho; 1999 Aug; 57(8):1855-8. PubMed ID: 10483265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
    Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
    Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.